MENU

ALLO Allogene Therapeutics Forecast, Technical & Fundamental Analysis

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases... Show more

Industry: #Biotechnology
ALLO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ALLO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALLO is expected to report earnings to rise 12.54% to -14 cents per share on October 29

Allogene Therapeutics ALLO Stock Earnings Reports
Q3'26
Est.
$-0.15
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.01
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.03
The last earnings report on August 12 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 2.76M shares outstanding, the current market capitalization sits at 614.97M.
A.I. Advisor
published General Information

General Information

a developer of allogeneic chimeric antigen receptor therapy

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
210 East Grand Avenue
Phone
+1 650 457-2700
Employees
152
Web
https://www.allogene.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DSFRX41.380.32
+0.78%
Domini Impact Equity Y
JCPRX25.66N/A
N/A
JPMorgan US Large Cap Core Plus R5
FAGCX263.14N/A
N/A
Fidelity Advisor Growth Opps I
BVEFX23.43N/A
N/A
Becker Equity Fund Retail
WPSIX48.54N/A
N/A
AB Concentrated Growth I

ALLO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with EDIT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
+1.14%
EDIT - ALLO
48%
Loosely correlated
+1.89%
RCKT - ALLO
45%
Loosely correlated
-3.74%
AXON - ALLO
44%
Loosely correlated
+0.10%
VYGR - ALLO
44%
Loosely correlated
N/A
FDMT - ALLO
43%
Loosely correlated
-2.37%
More
Allogene Therapeutics (ALLO) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com